Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study identified two distinct trichoscopic patterns in the mid-frontal scalp of patients with frontal fibrosing alopecia who also display clinical features of androgenetic alopecia.

This review discusses the mechanisms and treatment strategies for age-related hair changes, such as androgenetic alopecia and hair graying, and reports no new clinical results.

In this study, five women with androgenetic alopecia experienced severe facial and limb hypertrichosis after using 5% topical minoxidil, which resolved after discontinuing the treatment.

This study presents a new model for androgenetic alopecia progression, explaining diffuse hair loss in women through 3D reconstructions of the arrector pili muscle and its relationship with the hair follicle stem cell niche.

In this study, five out of six patients treated with vemurafenib for metastatic melanoma experienced hair loss, which improved after topical steroid treatment.

This article reviews current diagnostic and treatment approaches for androgenetic alopecia but reports no new results, focusing on its progression and medical management options.

In this study, five women with androgenetic alopecia developed severe hypertrichosis on the face and limbs after using 5% topical minoxidil, which resolved after discontinuing the treatment.

This study reported that low-dose oral minoxidil combined with a 5α-reductase inhibitor improved hair density in most men with female pattern hair loss after 6 months or more of treatment.

This case report describes androgenetic alopecia in two young siblings, highlighting its occurrence in children and suggesting a possible familial pattern given their mother's similar condition.

This report reviews various presumptive factors contributing to diffuse hair loss in women, emphasizing the need for comprehensive assessment to identify potential underlying causes; it presents no new clinical results.

This study found that standardized scalp massages may help stabilize or regrow hair in individuals with androgenic alopecia, as perceived by the participants themselves.

This case report describes a Taiwanese woman with lipedematous alopecia, highlighting rare mucin deposition as a feature that warrants further investigation.

This case report highlights the importance of considering telogen effluvium in young men with hair loss resembling male androgenetic alopecia to prevent misdiagnosis and unnecessary treatment.

This report describes a case where a 24-year-old woman developed severe ear and face hypertrichosis after using 5% topical minoxidil, which resolved three months after discontinuation.

This study found that women with post-COVID alopecia showed a diffuse telogen effluvium pattern and distinct trace element imbalances, such as reduced copper and increased selenium levels, helping differentiate this condition from androgenetic alopecia.

This study reported that most androgenetic alopecia patients in Trujillo were male, aged 31–39, with a family history of the condition, showing specific hair loss patterns and a disease duration of 1–5 years.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

This case report highlights how trichoscopy enabled the diagnosis of androgenetic alopecia in a woman experiencing diffuse hair loss, emphasizing its utility as a diagnostic tool.

This article discusses androgenetic alopecia, emphasizing its prevalence, characteristics, and the importance of prompt diagnosis and treatment but reports no new clinical results.

This review discusses the pathogenesis and patterns of androgenetic alopecia in men and suggests further research due to the condition's prevalence and implications; it reports no new clinical results.

This review identified alopecia as a significant cosmetic side effect of antiseizure medications, particularly with valproate, lamotrigine, and carbamazepine, noting that hair loss often improves after dose adjustment.

This article reviews alopecia areata as a chronic autoimmune disease affecting hair follicles and discusses its association with other autoimmune conditions, but provides no new clinical findings.

This article reviews alopecia areata incognita, a rare condition mostly seen in young women, and discusses its similarities and differences with telogen effluvium; however, it reports no new clinical findings.

This case report describes alopecia universalis-like hair loss occurring in two patients with cutaneous T cell lymphoma, providing clinical, dermoscopic, and pathologic features to help differentiate it from alopecia areata universalis.

This article discusses reported cases of diffuse scalp hair thinning in women using amphetamines and suggests no clear cause-effect relationship with amphetamine use based on available evidence.

This study reported that among patients aged 19 to 60 who experienced hair loss after COVID-19, a treatment involving a complex drug and peptide lotion led to hair improvement in 92% of cases, with good tolerability and no reported side effects.

In this study, the researchers reported that women with diffuse telogen alopecia who took Wolvit® (biotin 5 mg) daily for 3 months showed a significant decrease in hair in the telogen phase and an increase in hair thickness and growth speed.

This case report discusses alopecia syphilitica in a young Belgian man, notes that hair loss was his only symptom, and highlights the improvement following penicillin treatment.

This study found that female pattern hair loss is more common in women with thyroid disease and is associated with the duration of the disease, while alopecia areata is not more frequent.

This paper reviews alopecia areata incognita, a condition causing diffuse hair loss without typical patches, and highlights the need for scalp biopsy for diagnosis, but reports no new findings.